Bio-Techne Corp TECH

72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
Revenue
563.00 642.99 714.01 738.69 931.03 1,105.60 1,136.70 1,159.06 1,219.64 1,215.04
Revenue Growth
12.82% 14.21% 11.04% 3.46% 26.04% 18.75% 2.81% 1.97% 5.23% (0.38%)
Cost of Revenue
188.46 210.85 240.52 255.50 298.18 349.10 366.89 389.34 429.36 415.97
Gross Profit
374.54 432.14 473.49 483.19 632.85 756.50 769.82 769.73 790.27 799.07
R&D Expenses
53.51 55.33 62.41 65.19 70.60 87.14 92.49 96.66 99.50 94.77
SG&A Expenses
200.44 240.64 264.36 260.58 324.95 372.77 378.38 466.38 588.52 452.42
Operating Income
120.58 136.18 146.72 157.42 237.30 296.59 298.94 206.69 102.26 251.89
Non-operating Income/Expense
(8.62) (10.23) (34.70) 119.06 (89.12) 4.80 39.72 (21.00) (3.79) (11.21)
Non-operating Interest Expenses
7.36 10.19 21.71 19.20 13.95 11.31 11.22 15.74 8.51 9.63
EBT
111.96 125.95 112.02 276.48 148.18 301.39 338.66 185.69 98.46 240.68
Income Tax Provision
35.88 (0.20) 15.94 47.18 8.59 38.29 53.22 17.58 25.06 58.82
Income after Tax
76.09 126.15 96.07 229.30 139.59 263.10 285.44 168.11 73.40 181.86
Non-Controlling Interest
— — 0.00 0.00 (0.82) (8.95) 0.18 0.00 0.00 —
Net Income Common
76.09 126.15 96.07 229.30 140.41 272.05 285.26 168.11 73.40 181.86
EPS (Basic)
0.52 0.84 0.64 1.50 0.91 1.73 1.81 1.07 0.47 1.17
EPS (Diluted)
0.52 0.82 0.62 1.46 0.87 1.66 1.76 1.05 0.46 1.16
Shares (Basic, Weighted)
149.25 149.90 151.12 152.80 154.99 156.87 157.18 157.71 157.52 155.96
Shares (Diluted, Weighted)
150.00 152.22 155.57 157.60 161.93 164.11 161.86 160.77 159.72 157.01
Gross Margin
66.53% 67.21% 66.31% 65.41% 67.97% 68.42% 67.72% 66.41% 64.80% 65.77%
EBIT Margin
21.42% 21.18% 20.55% 21.31% 25.49% 26.83% 26.30% 17.83% 8.38% 20.73%
EBT margin
19.89% 19.59% 15.69% 37.43% 15.92% 27.26% 29.79% 16.02% 8.07% 19.81%
Net Profit Margin
13.51% 19.62% 13.46% 31.04% 15.08% 24.61% 25.10% 14.50% 6.02% 14.97%
Free Cash Flow Margin
22.83% 23.24% 21.88% 20.78% 33.07% 25.36% 19.02% 20.37% 21.03% 21.66%
EBITDA
180.62 200.64 224.89 240.16 325.04 397.66 406.18 318.40 212.16 349.25
EBIT
120.58 136.18 146.72 157.42 237.30 296.59 298.94 206.69 102.26 251.89
Income from Continuous Operations
76.09 126.15 96.07 229.30 139.59 263.10 285.44 168.11 73.40 181.86
Consolidated Net Income/Loss
76.09 126.15 96.07 229.30 139.59 263.10 285.44 168.11 73.40 181.86
EPS (Basic, from Continuous Ops)
0.51 0.84 0.64 1.50 0.90 1.68 1.82 1.07 0.47 1.17
EPS (Basic, Consolidated)
0.51 0.84 0.64 1.50 0.90 1.68 1.82 1.07 0.47 1.17
EPS (Diluted, from Cont. Ops)
0.51 0.83 0.62 1.45 0.86 1.60 1.76 1.05 0.46 1.16
Shares (Diluted, Average)
150.00 152.22 155.57 157.60 161.93 164.12 161.86 160.77 159.72 157.01
EPS (Diluted, Consolidated)
0.51 0.83 0.62 1.45 0.86 1.60 1.76 1.05 0.46 1.16
EBITDA Margin
32.08% 31.20% 31.50% 32.51% 34.91% 35.97% 35.73% 27.47% 17.40% 28.74%
Operating Cash Flow Margin
25.53% 26.50% 25.44% 27.78% 37.83% 29.42% 22.38% 25.80% 23.58% 24.04%

Fold the line items

In millions of $ except per-share values · columns are period end dates